Compare FMC Corp (FMC) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Tilray Brands Inc — how do they compare? FMC Corp trades at $10.22 (market cap $1.30B), while Tilray Brands Inc trades at $4.68 (market cap $649.42M). The key difference: FMC Corp is far larger — about 2× Tilray Brands Inc's market cap, and FMC Corp pays a 3.07% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| FMC | TLRY | |
|---|---|---|
Market Cap | $1.30B | $649.42M |
Sector | Basic Materials | Health |
52-Week High | $40.69 | $21.00 |
52-Week Low | $10.01 | $3.88 |
Enterprise Value | $5.11B | $816.55M |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC stock trades at $10.46, down 1.23% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $2.24 billion in 2025, with negative profitability margins, though recent quarters show mixed earnings beats. Analyst consensus is divided, with a $11.60 price target, while recent news highlights revenue challenges and strategic moves like a $400 million investment from Tessenderlo Group to reduce debt.
The outlook remains cautious due to persistent losses and weak revenue trends, but debt reduction efforts and cost controls offer some stability. Key risks include competitive pressures and macroeconomic headwinds, while the current valuation metrics like P/S of 0.4 may attract value investors if operational improvements materialize.
TLRY trades at $4.71, up 6.56% today, with a bullish technical signal from moving averages but mixed oscillators. Revenue grew to $821M in 2025, yet the company posted a net loss of -$2.19B, reflecting profitability challenges. Recent news highlights growth initiatives, including a partnership with Wolverhampton Wanderers and a new THC pouch launch. The stock remains volatile, with a low P/S of 0.58 and P/B of 0.4, suggesting potential undervaluation amid ongoing losses.
Outlook is cautious; TLRY's path to profitability hinges on revenue growth and cost management. Risks include persistent losses, high debt, and regulatory uncertainty. Analyst consensus is mixed, with 25% buy ratings but 65% hold, indicating skepticism. Investors should weigh growth potential against financial instability and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
